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1. Introduction 
In the last few years the primary structure of 
several glycoprotein hormones of animal origin such 
as ovine, bovine and porcine luteinizing hormones* 
[l-7] and bovine thyroid-stimulating hormone [8] 
were elucidated. Recently, Bahl et al. [9] presented 
the complete sequences of the subunits cr and fl of 
human chorionic gonadotropin. Different laboratories 
are now focusing their efforts on the elucidation of 
the primary structure of LH& and fl subunits of human 
origin. 
This task is made difficult by the scarcity and 
heterogeneity of human pituitaries and difficulties 
encountered in obtaining pure subunits in good yield 
[ 10, 111. We recently described a method for the dis- 
sociation of human LH and the isolation of its sub- 
units in excellent yield [ 121. The high degree of 
purity of our preparations allowed us to approach the 
elucidation of the subunit sequences. 
At the last Laurentian Hormone Conference, 
Papkoff presented the complete structure of human- 
LH (Y [ 131. Simultaneously, Ward [ 141, Shome [ 1.51 
* Abbreviations: 
LH : Luteinizing hormone. 
TSH : Thyroid-stimulating hormone. 
HCG: Human chorionic gonadotropin. 
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and we [ 161 presented preliminary data concerning 
the primary structure of human-LH/3 subunit. We 
propose here an amino acid sequence for the human 
LHP chain and its relationships to the fl subunits of 
pituitary gonadotropins from other species and to that 
of human chorionic gonadotropin. 
2. Experimental 
2.1. Methods 
Human LHp was prepared as previously described 
[ 121. The protein was reduced by dithiothreitol and 
alkylated by recrystallized iodoacetic acid according 
to Koningsberg [ 171. Methods of amino acid analysis 
and tryptic hydrolysis have been described previously 
[5-71. Thermolysin (Calbiochem) digestions were 
carried out at pH 8.2 in 0.125 M ammonium bicarbon- 
ate and 0.01 M calcium acetate for 2 hr at 37” with a 
weight ratio of enzyme to peptide of l/100. Tryptic 
peptides from the reduced and carboxymethylated 
protein were first fractionated on a Sephadex G-50 
fine (Pharmacia) column (2 X 200 cm) using 0.05 M 
ammonium bicarbonate as developing buffer. 
Further purification was achieved by gel filtration 
on Sephadex G-25 superfine (Pharmacia) and ion 
exchange chromatography on Dowex 50 X 2 (Bio-Rad) 
using pyridine-acetate buffers. Separations of pep- 
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tides were also performed on a peptide analyzer 
(Technicon) equipped with the Ultrograd 11300 
(LKB). Final purification was achieved by preparative 
electrophoresis [5,6] or by preparative paper chro- 
matography using n-butanol-pyridine-acetic acid- 
water (30:20:6:24) system or pyridine-n-propanol- 
water (20:37.5:30) system [18]. Amino-terminal 
amino acid sequences were determined according to 
Gray [ 191. Dansyl amino acids were identified by 
thin-layer chromatography on polyamide sheets [20]. 
Digestions with carboxypeptidases A and B were used 
to elucidate carboxy-terminal amino acids of proteins 
[61. 
HCGP 
HLHf, 
HCGP 
HLHP 
LYS +wl 
5 
Due to limitation of material, carboxy-terminal 
residues were also identified by the selective tritiation 
method described by Holcomb et al. [21]. Tritiated 
and non tritiated amino acids were isolated by electro- 
phoresis (formic acid-acetic acid-water; 20: 75: 100, 
pH 1 S) followed by chromatography (n-butanol- 
pyridine-acetic acid-water; 30:20:6:24). Elution of 
amino acids was performed with 0.01 M ammonium 
hydroxide, the eluate was lyophilized and the residue 
dissolved in a scintillation mixture (5 g PPO, 0.1 g 
dimethyl POPOP per Q of toluene). The radioactivity 
was measured with a Packard Model 3380 liquid 
scintillation spectrometer. 
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Fig. 1. The amino acid sequence of human luteinizing hormone p subunit. Ti indicates tryptic peptides; Thi, peptides resulting 
from thermolysin digestion of tryptic peptides. CHO symbolizes polysaccharide prosthetic group; R, an unidentified acyl group. 
Parts of sequences shown in parentheses represent gaps in the elucidation of sequence. Non identical residues in HCGf.3 are in- 
dicated above the LHp sequence. 
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Tryptophan containing peptides were identified by 
staining with Erlich reagent [22]. 
3. Results and discussion 
The amino acid sequence of human luteinizing 
hormone /I subunit (fig. 1) was established according 
to both NH, - and COOH-terminal sequences of tryp- 
tic peptides (Ti) of the reduced and S-carboxy- 
methylated protein. As previously described for other 
proteins the arginine-proline bond (6-7) was found 
to be resistant to tryptic hydrolysis, The lysine- 
glutamic acid bond (20-21) also exhibited an un- 
expected stability toward trypsin. Unusual cleavages 
were observed at leucine-serine bond (86-87) and 
leucine-threonine bond (108-109). 
After partial elucidation of their sequence, the 
large tryptic peptides were further digested with 
thermolysin. The resulting peptides (Th) were 
analysed for their composition and submitted to 
sequential degradations. 
Both tryptic and thermolytic peptides were ordered 
on the basis of their homology with bovine LH@ and 
HCGfl sequences. 
A most difficult task was the elucidation of the 
COOH-terminal sequence of human LHp subunit. In- 
deed, T12 was assigned as the COOH-terminal tryptic 
peptide, its composition and NH2-terminal sequence 
being similar to the corresponding sequence of Lyle 
from other species or to that of HCGP. Due to severe 
limitation of material, this peptide could not be sub- 
mitted to further cleavage, so that a gap in the elucida- 
tion of its sequence (Glx-Asx-Ser-Lys) could not 
be filled. Moreover, selective tritiation revealed several 
labeled amino acids, glycine being predominant. This 
possibly indicates a COOH-terminal heterogeneity of 
the protein, as seen in the case of ovine, bovine and 
porcine LH@ [l, 5, 61. 
No free amino-terminal residue was identified on 
the reduced and carboxymethylated human Lw by 
the dansyl labeling technique. The NH2-terminal 
peptide Tl had an electrophoretical mobility at pH 3.7 
similar to the blocked NH2-terminal peptide of the 
bovine and porcine p subunits. Nevertheless, a trace 
of serine was observed by the dansyl method applied 
to this peptide. This observation suggests that the 
blocked NHz-terminal residue could be unmasked 
during the various steps of the isolation of this peptide. 
In our work, sequence 5-9 was not determined. 
Recently Ward [14] accomplished the determination 
of 26 steps from the NH2-terminal end of the mole- 
cule and showed that positions 5 to 9 corresponded 
to a Leu-Arg-Pro-Trp-Cys sequence. The amino 
acid compositions of both T2 and T3 peptides in our 
work were indeed in agreement with these data. 
Our sequence of human LHp differs in three 
respects from the provisional data proposed by Shome 
and Parlow [ 151. We found leucine and valine residues, 
respectively, in positions 44 and 52 whereas Shome 
placed valine and leucine residues. The most important 
discrepancy occurs in the 28-30 portion of the molec- 
ule where we assigned the sequence Thr-Val-Asx in- 
stead of Asn-Val-Thr as reported by Shome and 
Parlow [ 151. As in both cases, the Asx residue is a 
presumed site of attachment for a polysaccharide side 
chain, it would be important to look for additional in- 
formation, concerning this part of the sequence. The 
28-30 sequence as defined by Shome and Parlow [ 151 
was identical to that found in HCGfl chain by Bahl et 
al. [9]. 
Compared with other glycoprotein hormories, human 
LH/3 showed a higher degree of holomogy with HCG/3 
than with LHfl subunits of animal origins (ovine, 
bovine and porcine). Indeed 86 positions of human 
LHp and HCGP are identical. Nevertheless, a striking 
difference exists between the pituitary and chorionic 
gonadotropin /3 subunits, the latter exhibiting an 
additional COOH-terminal portion of 24 amino acids. 
Seventy six positions were found to be identical in 
bovine LHp (or ovine LH@) and human LH& 
It is interesting to note that the sequence variability 
already observed in bovine LHa [23] was also present 
in the sequence of human LH/3. Indeed, we isolated a 
peptide T6b similar in sequence to T6a fragment 
except that isoleucine is replaced by a glycine residue. 
Furthermore, Ward recently reported [ 141 sequence 
variability in positions 8, 13 and 15 of human LHfl, 
tryptophan, asparagine and threonine being replaced 
by valine, arginine and isoleucine residues, respective- 
ly. It is striking to note that variability in positions 13 
and 15 implies that a possible recognition site for 
carbohydrate linkage might exist in that portion of 
human LHP structure. LH@ subunits from other 
species possess only one carbohydrate unit on the 
asparagine 13, whereas polysaccharide prosthetic 
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groups are located at positions 13 and 28 in HCG& 
4. Conclusion 
The amino acid sequence of human LHP was 
established using only 3 pmoles of reduced and 
S-carboxymethylated protein. Trypsin and thermo- 
lysin were used for protein and peptide cleavages, 
respectively. Only a single gap in the sequence remains 
to be filled between positions 11 l-l 14. 
It was shown that human LHP HCG@ exhibit 86 
identical residues within their common sequence 
(positions l-l 12) the extent of homology being less 
with LH/3 subunits from ovine, bovine and porcine 
species. 
As for bovine LHo subunit, sequence variability 
was also demonstrated for human LH(3. 
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